Storia in 12 fonti

Lilly dives into vaccine research with 3 biotech buyouts

Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.

Raccontata da

pharmaceutical-technology.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo3 mesi fa

Lilly dives into vaccine research with 3 biotech buyouts

Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.

originale

Timeline cronologica

martedì 26 maggio 2026·biopharmadive.com
Lilly dives into vaccine research with 3 biotech buyouts
Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.
martedì 26 maggio 2026·qz.com
Eli Lilly acquires three vaccine developers for $3.8 billion
The deals give Lilly vaccines targeting shingles, bacterial pathogens, and Epstein-Barr virus as it expands beyond weight loss drugs

Lilly dives into vaccine research with 3 biotech buyouts

Confronto fonti

Lilly dives into vaccine research with 3 biotech buyouts

Timeline cronologica

Lilly dives into vaccine research with 3 biotech buyouts

Eli Lilly acquires three vaccine developers for $3.8 billion

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

Three vaccine biotechs to be bought by Lilly for up to $3.8B

Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - UPI.com

Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology

Eli Lilly acquires three vaccine developers for $3.8 billion

Three vaccine biotechs to be bought by Lilly for up to $3.8B

Eli Lilly to buy three small vaccine developers

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology

Eli Lilly spending $3.8 billion to buy vaccine makers

Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - UPI.com

Eli Lilly comprará 3 empresas fabricantes de vacunas por casi 4 mil mdd; ampliará investigación de enfermedades infecciosas | El Universal

What's Going On With Eli Lilly Stock Tuesday? - Eli Lilly (NYSE:LLY)

Eli Lilly’s $4 Billion Vaccine Bet

Perché Eli Lilly fa scorpacciata di biotech focalizzate sui vaccini - Startmag

Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know